It was fourth time lucky for Remgro, which has gained support from Mediclinic for its new, higher offer to buy out the private hospital operator after being rejected three times.

Mediclinic shares logged their best gain since mid-October on Thursday after the group said it was willing to consider an improved proposal from a consortium including big shareholder Remgro that values it at £3.7bn (R74bn)...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.